Aurora Oncology’s Success Story

Started with philanthropic funds, Aurora Oncology is a prime example of how new discoveries can be moved from the research bench to products that benefit patients’ lives.

Ghost 9/18/20 Ghost 9/18/20

The CU Anschutz Campus.

The Anschutz Campus is a leading research institution

Ghost 9/18/20 Ghost 9/18/20

Tom Flaig, MD Chairs the NCCN Bladder Panel.

Dr. Flaig is a leading bladder cancer researcher

Ghost 7/6/20 Ghost 7/6/20

Won Park heads Aurora’s Nano research.

Dr. Park is a leading Boulder campus researcher.

Aurora Oncology’s Success Story

The CU Anschutz Campus.

Tom Flaig, MD Chairs the NCCN Bladder Panel.

Won Park heads Aurora’s Nano research.

Aurora Oncology - a flexible future